Vitamin C Works for Sepsis. Will It Work for Coronavirus?by Dr. Joseph Mercola for Mercola
GNN Note – Right now we are taking 1,000mg Vitamin C, oil of oregano, astragalus, aloe juice and fish oil on a daily basis. The idea is to boost the immune system. As this week progresses we will be adding turmeric, ginger and garlic to our daily supplements and moving to Liposomal Vitamin C instead of the common variety. Not sure if there is a big difference but we are willing to try. This should supercharge the immune and blood systems!
According to the most comprehensive global analysis1,2,3 done to date, sepsis is responsible for 1 in 5 deaths worldwide each year, killing 11 million out of 56 million people in 2017 alone. The researchers call the finding “alarming,” as their updated figures are double that of previous estimates.
Sepsis is a life-threatening condition triggered by a systemic infection that causes your body to overreact and launch an excessive and highly damaging immune response.
Unless promptly diagnosed and treated, it can rapidly progress to multiple-organ failure and death, so it’s crucial to be on the lookout for its signs and symptoms4,5,6 whenever you’re ill or in the hospital.
This includes cases of suspected influenza, as sepsis can mimic many of the signs and symptoms of flu. In fact, as discussed in “The Alarming Reason Some People Die From the Flu,” sepsis is one of the leading causes for influenza deaths.7
Vitamin C Protocol Lowers Sepsis Mortality
The good news is, a protocol of intravenous (IV) vitamin C with hydrocortisone and thiamine (vitamin B1) has been shown to dramatically improve chances of survival.8
This sepsis treatment protocol was developed Dr. Paul Marik, a critical care doctor at Sentara Norfolk General Hospital in East Virginia. His retrospective before-after clinical study9,10 showed giving patients 200 mg of thiamine every 12 hours, 1,500 mg of ascorbic acid every six hours, and 50 mg of hydrocortisone every six hours for two days reduced mortality from 40% to 8.5%.
Importantly, the treatment has no side effects and is inexpensive, readily available and simple to administer, so there’s virtually no risk involved. More recent research,11,12 published online January 9, 2020, found Marik’s sepsis protocol lowered mortality in pediatric patients as well.
The study was performed at Ann & Robert H. Lurie Children’s Hospital of Chicago, and as noted by Science Daily,13 the preliminary data from this study “supports the promising outcomes seen in adults.” Between January 2014 and February 2019, 557 pediatric patients with septic shock met the criteria for inclusion in the study.
Forty-three received Mariks’s vitamin C-B1-hydrocortisone protocol, 181 received hydrocortisone-only therapy, and 333 received neither of these treatments. The 43 patients receiving the vitamin C treatment were matched based on clinical status with 43 untreated controls and 43 hydrocortisone-only patients.
At the 30-day mark, controls and the hydrocortisone-only groups had a mortality rate of 28% while the treatment group had a mortality rate of just 9%. At 90 days, 35% of the controls and 33% of those receiving hydrocortisone-only had died, compared to just 14% of the treatment group.14
As noted by the authors, “Our results suggest that HAT [hydrocortisone, ascorbic acid and thiamine] therapy, when administered early in the clinical course, reduces mortality in children with septic shock.”